Treatment of PC-3 tumors with the three dendriplex formulations (DAB-Lf dendriplexes encoding TNFα, TRAIL, or IL12) was characterized by a high variability of response to treatment within the same group of mice and an overall reduced tumor growth compared to naked DNA treatment (Figure 3a). The gene discussed is TNFSF10; the disease is neoplasm.